» Articles » PMID: 32986231

Relaxation Versus Exercise for Improved Quality of Life in Lymphoma Survivors-a Randomised Controlled Trial

Overview
Journal J Cancer Surviv
Specialty Oncology
Date 2020 Sep 28
PMID 32986231
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Lymphoma survivors experience persisting needs as a consequence of disease and treatment, which have an impact on quality of life (QoL). There is evidence supporting the use of relaxation and exercise to improve QoL, but there is no agreement on which is more beneficial. This study aims to compare a relaxation intervention versus an exercise intervention to determine which has a greater impact on QoL post-chemotherapy.

Methods: Eligible participants (n = 46) were randomised to a relaxation or exercise intervention for 12 weeks. QoL was assessed at baseline, 6 weeks and post-intervention using the European Organisation for Research and Treatment of Cancer QoL Questionnaire Core 30 (EORTC QLQ-C30) questionnaire, which is a valid and reliable tool. The summary score and all EORTC domains were assessed.

Results: There was a significant difference in QoL post-intervention between groups (p = 0.029) while adjusting for baseline QoL, with the exercise group demonstrating a larger improvement. Within-group QoL significantly improved pre- to post-intervention in both the relaxation (p = 0.036) and exercise (p = 0.004) groups.

Conclusions: A self-management intervention of either exercise or relaxation can help significantly improve QoL in lymphoma survivors following chemotherapy. While exercise is preferred, a relaxation intervention would also have a beneficial impact on QoL.

Implications For Cancer Survivors: Lymphoma survivors should be routinely screened and those with decreased QoL referred for an exercise programme, or relaxation for survivors who are unable to exercise or choose not to. A home-based programme can have a significant positive impact on QoL and is a feasible and effective method in the current climate.

Trial Registration Number: Clinical Trials ID NCT02272751.

Citing Articles

Effects of the CALM intervention on cancer-related fatigue and heart rate variability in NSCLC: a randomized trial.

Chai J, Gan C, Jia Y, Huang R, Li A, Ge H Future Oncol. 2024; 20(39):3289-3300.

PMID: 39548708 PMC: 11633391. DOI: 10.1080/14796694.2024.2428586.


Limited Evidence for the Benefits of Exercise in Older Adults with Hematological Malignancies: A Systematic Review and Meta-Analysis.

Jarden M, Lindholm S, Kaldan G, Gronset C, Larsen R, Larsen A Cancers (Basel). 2024; 16(17).

PMID: 39272820 PMC: 11393877. DOI: 10.3390/cancers16172962.


Guided imagery for anxiety disorder: Therapeutic efficacy and changes in quality of life.

Kumari D, Patil J Ind Psychiatry J. 2024; 32(Suppl 1):S191-S195.

PMID: 38370950 PMC: 10871407. DOI: 10.4103/ipj.ipj_238_23.


Survivorship care for patients curatively treated for Hodgkin's and non-Hodgkin's lymphoma: a scoping review.

Powis M, Hack S, Fazelzad R, Hodgson D, Kukreti V J Cancer Surviv. 2023; .

PMID: 38048010 DOI: 10.1007/s11764-023-01500-3.


Self-managed physical activity in cancer survivors for the management of cancer-related fatigue: A scoping review.

Campanini I, Ligabue M, Bo M, Bassi M, Lusuardi M, Merlo A PLoS One. 2022; 17(12):e0279375.

PMID: 36542639 PMC: 9770433. DOI: 10.1371/journal.pone.0279375.

References
1.
Damlaj M, El Fakih R, Hashmi S . Evolution of survivorship in lymphoma, myeloma and leukemia: Metamorphosis of the field into long term follow-up care. Blood Rev. 2018; 33:63-73. DOI: 10.1016/j.blre.2018.07.003. View

2.
Ciavarella S, Minoia C, Quinto A, Oliva S, Carbonara S, Cormio C . Improving Provision of Care for Long-term Survivors of Lymphoma. Clin Lymphoma Myeloma Leuk. 2017; 17(12):e1-e9. DOI: 10.1016/j.clml.2017.08.097. View

3.
Wu H, Harden J . Symptom burden and quality of life in survivorship: a review of the literature. Cancer Nurs. 2014; 38(1):E29-54. DOI: 10.1097/NCC.0000000000000135. View

4.
Hackett F, Dowling M . Lymphoma survivors' experiences at the end of treatment. J Clin Nurs. 2018; 28(3-4):400-409. DOI: 10.1111/jocn.14658. View

5.
Monterosso L, Taylor K, Platt V, Lobb E, Krishnasamy M, Musiello T . A qualitative study of the post-treatment experiences and support needs of survivors of lymphoma. Eur J Oncol Nurs. 2017; 28:62-68. DOI: 10.1016/j.ejon.2017.03.002. View